Simbec Research Ltd.

Simbec-Orion, legally known as Simbec Research Ltd., is a United Kingdom-based contract research organisation (CRO) headquartered in Merthyr Tydfil, Wales. It operates as a full-service CRO, delivering clinical trial management services from first-in-human and Phase I studies through to Phase III. The company describes itself as a responsive and agile organisation that combines the broad experience of a large CRO with the personal service and care of a smaller one, positioning itself as a trusted partner for small and mid-size drug developers. The organisation's therapeutic expertise spans some of the most challenging areas of clinical development, including oncology, rare and orphan diseases, respiratory medicine, dermatology, vaccines and anti-infectives. Its service portfolio covers clinical pharmacology, first-in-human and Phase I trials, Phase 1b/Phase 2a proof-of-concept studies, pharmacokinetic and food-effect studies, drug-drug interaction studies, central laboratory services, bioanalytical laboratory services, routine safety testing, immunoassays, clinical and medical writing, and early regulatory support. Simbec-Orion operates a purpose-built clinical pharmacology facility where it conducts all types of studies, with the majority of its work involving investigational medicinal products across all drug delivery routes. Simbec-Orion is a Caidya® company, having been acquired by or merged into the Caidya group, a global clinical research organisation. The company states that it has been delivering clinical trial management services for almost five decades, giving it a long heritage in the clinical research sector. It emphasises stable teams, noting an attrition rate of under 10% and that a significant proportion of its colleagues have spent much of their careers with the organisation. The company's stated mission is to improve patients' lives by applying its skills, experience and knowledge to advance medicine through flexible, innovative, high-quality solutions delivered with integrity. Its corporate culture is defined by values including caring ambitiously, tight-knit teams, dedication to delivery, forward-thinking, and being radically honest. Simbec-Orion maintains a comprehensive set of corporate policies covering privacy, anti-bribery and anti-corruption, environmental, social and governance (ESG), modern slavery and human trafficking, sustainable procurement, business ethics, and health and safety, and publishes annual modern slavery statements and sustainability reports.

Simbec Research Ltd. is a United Kingdom clinical research organisation based in Merthyr Tydfil, Wales. According to its own corporate communications, the company has been delivering clinical trial management services for almost five decades, placing its origins in the late 1970s or early 1980s. Over that period it developed into a full-service contract research organisation (CRO) capable of running studies from first-in-human and Phase I through to Phase III. The company built its reputation on clinical pharmacology and early-phase research, operating a purpose-built facility where it conducts all types of studies, with the majority of its work involving investigational medicinal products across all drug delivery routes. Its service range expanded to include central laboratory services, bioanalytical laboratory services, routine safety testing, immunoassays, clinical and medical writing, and early regulatory support, alongside full clinical trial management. Simbec-Orion developed particular expertise in challenging therapeutic areas, including oncology, rare and orphan diseases, respiratory medicine, dermatology, vaccines and anti-infectives. It positioned itself as a specialist partner for small and mid-size drug developers, offering tailor-made and scalable solutions with a centralised leadership team. At some point the business became part of the Caidya group, a global clinical research organisation, and now operates under the Simbec-Orion name as a Caidya® company. Under this ownership, Simbec-Orion continues to deliver early- to late-phase clinical trials globally, maintaining its specialist focus on rare diseases and oncology while benefiting from the broader capabilities of the Caidya group. The company emphasises stable teams, reporting an attrition rate of under 10% and noting that many colleagues have spent much of their careers with the organisation.

• Simbec Research Ltd. established in Merthyr Tydfil, Wales, beginning its clinical research operations (approximate, based on 'almost five decades' of service).

• Developed into a full-service CRO offering clinical trial management from first-in-human and Phase I through Phase III.

• Became part of the Caidya group and now operates as Simbec-Orion, a Caidya® company.

A responsive, agile full-service CRO combining large-organisation experience with small-organisation personal service, specialising in rare diseases and oncology for small and mid-size drug developers.

• Clinical trial management (Phase I–III)

  Full-service clinical development solutions from first-in-man through Phase III, including fully integrated trials or stand-alone support.

• Clinical pharmacology

  All types of studies conducted at a purpose-built site, with 90% of work involving investigational medicinal products across all drug delivery routes.

• Central laboratory services

  Central laboratory support for clinical trials across challenging therapeutic areas.

• Bioanalytical laboratory services

  Bioanalytical testing and immunoassays supporting clinical development.

• Early regulatory support

  Support for early regulatory engagement, including scientific advice to support clinical development.

1. 1Your Clinical Research Organisation (CRO): Simbec-Orionsimbecorion.com
2. 2About us | Clinical Research Organisation | Simbec-Orionsimbecorion.com
3. 3CRO Services | Supporting your clinical development | Simbec-Orionsimbecorion.com
4. 4Corporate Policies | Simbec-Orionsimbecorion.com
5. 5Simbec Research Ltd. (United Kingdom) - Wikidatawikidata.org